StockData
Cellectar Biosciences, Inc. logo

Cellectar Biosciences, Inc. (CLRB) stock

CLRBNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 6/30
$0.92−0.09 (-8.88%)

Close on Nov 17, 2026Market cap $8.70MP/E –Yield –

Cellectar Biosciences price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Cellectar Biosciences's price to book ratio was 0.3× on Nov 11, 2026, against 1.4× a year earlier. Over the last 5 years it ranged from 0.3× to 13.9×, with a median of 1.3×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20260.3×−0.8
2025Dec 31, 20251.2×+0.4
2024Dec 31, 20240.8×−13.1
2023Jul 31, 202313.9×+12.9
2022Dec 30, 20221.0×−0.1
2021Dec 31, 20211.1×−2.4
2020Dec 31, 20203.4×+1.7
2019Dec 31, 20191.7×+1.3
2018Dec 31, 20180.4×−2.0
2017Dec 29, 20172.4×+1.6
2016Dec 30, 20160.8×−7.4
2015Dec 31, 20158.2×+5.9
2014Dec 31, 20142.4×−2.4
2013Dec 31, 20134.8×+1.8
2012Dec 31, 20123.0×+1.0
2011Dec 30, 20112.0×–

More Cellectar Biosciences figures

See a number that looks wrong?